Overview

A Study of TD-1211 in Subjects With Opioid-Induced Constipation (OIC)

Status:
Completed
Trial end date:
2012-08-01
Target enrollment:
Participant gender:
Summary
A Single-Blind, Pilot Study to Determine the Tolerability and Safety of TD-1211 in Subjects with Opioid-Induced Constipation
Phase:
Phase 2
Details
Lead Sponsor:
Theravance Biopharma
Theravance Biopharma R & D, Inc.
Treatments:
Analgesics, Opioid